637-84-3|N-[N-(N-Glycylglycyl)glycyl]-glycine

Current Location
Home Products
detail

N-[N-(N-Glycylglycyl)glycyl]-glycine | CAS:637-84-3

N-[N-(N-Glycylglycyl)glycyl]-glycine

Name：N-[N-(N-Glycylglycyl)glycyl]-glycine
CAS：637-84-3
Synonyms：Glycine tetrapeptide; Glycylglycylglycylglycine; H-Gly-Gly-Gly-Gly-OH; NSC 89178; Tetraglycine
Molecular Formula：C₈H₁₄N₄O₅
Molecular Weight：246.22
EINESC：211-303-4

Description

Properties

Melting point	573.15 ºC**
Density	1.393±0.06 g/cm3 (20 º

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Determination of piroxicam in pharmaceutical formulations and urine samples using europium-sensitized luminescence.Al-Kindy SMZ, et al. Journal of Luminescence, 127(2), 291-296 (2007) A simple spectrofluorimetric method for determination of piroxicam and propranolol in pharmaceutical preparations.Tabrizi AB Journal of food and drug analysis, 15(3) (2007) Anal. Profiles Drug Subst., 15, 509-531 (1986) Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations.Nagaralli BS, et al. Journal of Pharmaceutical and Biomedical Analysis, 29(5), 859-864 (2002) Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin.Amin AS Journal of Pharmaceutical and Biomedical Analysis, 29(4), 729-736 (2002)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News